ABT-333

AbbVie Hepatitis C Combo Cures Almost All in Late Study
Bloomberg
Mon, 03/3/14 - 06:46 pm
AbbVie
hepatitis C
ABT-450
ABT-267
ABT-333
Gilead Sciences
Bristol-Myers Squibb
Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market
Seeking Alpha
Sun, 11/24/13 - 12:24 pm
Gilead Sciences
AbbVie
hepatitis
hepatitis C
sofosbuvir
ABT-450
ABT-333
ABT-267
Don't Crown the Hepatitis C Drug Winner Just Yet
Motley Fool
Tue, 11/19/13 - 07:35 am
hepatitis C
Gilead Sciences
ABT-333
Ribavirin
ABT-450
ritonavir
ABT-267
AbbVie
AbbVie hepatitis C drugs knock out virus at 8 weeks
Reuters
Tue, 04/23/13 - 07:50 am
hepatitis C
AbbVie
ABT-450
ABT-333
ABT-267
Abbott Hep C Therapy Achieves Almost-Perfect Cure Rate
TheStreet.com
Mon, 10/15/12 - 11:37 am
Abbott Labs
hepatitis C
ABT-450
ABT-267
ABT-333
Gilead
Pharmasset Falls on Rival Abbott Hepatitis C Therapy Results
Reuters
Sat, 10/22/11 - 12:20 pm
Pharmasset
Abbott Laboratories
hepatitis C
ABT-450
protease inhibitors
ABT-333
ABT-072